Intellia Therapeutics Awarded Innovation Passport in the Uni

Intellia Therapeutics Awarded Innovation Passport in the United Kingdom for NTLA-2002, an Investigational Genome Editing Treatment for Hereditary Angioedema - read this article along with other careers information, tips and advice on BioSpace

Related Keywords

Cambridge , Cambridgeshire , United Kingdom , Ian Karp , Alina Li , Rebecca Spalding , John Leonard , Twitter , Intellia Therapeutics Inc , Toxicology Centre , Nasdaq , Regulatory Agency , Exchange Commission , Development Profile , National Institute For Health , Corporate Communications , Clinical Program , Scottish Medicines Consortium , Innovation Passport , Access Pathway , Intellia President , Chief Executive Officer John Leonard , All Wales Therapeutics , National Institute , Care Excellence , Target Development Profile , Nobel Prize Winning , Intellia Therapeutics , Private Securities Litigation Reform Act , Vice President , Investor Relations , Resume , Careers , Ntellia Therapeutics Awarded Innovation Passport In The United Kingdom For Ntla 2002 , N Investigational Genome Editing Treatment For Hereditary Angioedema , Iospace , Advice ,